al-Sereiti M R, Turner P, Gale E A
Department of Clinical Pharmacology, St Bartholomew's Hospital, London, UK.
Postgrad Med J. 1991 Apr;67(786):347-9. doi: 10.1136/pgmj.67.786.347.
The effect of bromocriptine on intraocular pressure has been investigated in a group of 8 diabetic patients with autonomic neuropathy, to test the hypothesis that bromocriptine exerts its ocular hypotensive action through presynaptic dopamine receptors. Bromocriptine eye drops (0.025%) produced a significant fall in intraocular pressure in a control group of 8 matched normal volunteers, but this effect was not seen in the eyes of the diabetic patients. These results are consistent with a presynaptic site of action of bromocriptine.
研究了溴隐亭对一组8例患有自主神经病变的糖尿病患者眼压的影响,以检验溴隐亭通过突触前多巴胺受体发挥其降眼压作用这一假说。在8名匹配的正常志愿者组成的对照组中,溴隐亭滴眼液(0.025%)可使眼压显著降低,但在糖尿病患者眼中未观察到这种效果。这些结果与溴隐亭的突触前作用位点一致。